Monocrotaline is a macrocyclic pyrrolizidine alkaloid that inhibits organic cation transporters OCT-1 and OCT-2. It demonstrates cytotoxic effects against HepG2 liver cancer cells in vitro and is widely utilized to establish rodent models of pulmonary arterial hypertension for in vivo research.